0001209191-16-089827.txt : 20160106
0001209191-16-089827.hdr.sgml : 20160106
20160106161859
ACCESSION NUMBER: 0001209191-16-089827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151216
FILED AS OF DATE: 20160106
DATE AS OF CHANGE: 20160106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRINT PAUL C
CENTRAL INDEX KEY: 0001236548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 161327046
MAIL ADDRESS:
STREET 1: 3030 CALLAN RD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-16
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001236548
GRINT PAUL C
C/O REGULUS THERAPEUTICS INC.
3545 JOHN HOPKINS CT., #210
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Stock Option (Right to Buy)
7.58
2015-12-16
4
A
0
30000
0.00
A
2015-12-16
2024-06-15
Common Stock
30000
30000
D
On June 16, 2014, the reporting person was granted an option to purchase 30,000 shares of common stock. The option vests only upon achievement of a performance-based milestone. The performance criteria were met, resulting in vesting of the option. Upon achievement of the milestone, fifty percent of the shares immediately vest with the remaining shares vesting over the 24 month period following the vesting commencement date, subject to the reporting person's continuous service to Regulus.
Christopher Aker, Attorney-in-Fact
2016-01-06